GlassScriptPhysician profile
Joshua Davis
NPI 1073072054
$3,219.29
in general payments reported to CMS, 2019-2025
8 companies · $1,427 in 2025
The $1,427 reported for 2025 was more than what 76% of Surgical Oncology providers received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $305 · 2021: $318 · 2022: $1,011 · 2023: $130 · 2024: $27.77 · 2025: $1,427.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,000 · Food and Beverage: $585.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,000.00 |
| Food and Beverage | $584.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,039.21 | 2021-2025 | Da Vinci Surgical System |
| Zimmer Biomet Holdings, INC. | $391.44 | 2021-2025 | A&E Medical / Sternalock Xp Rigid Fixation System |
| Medical Device Business Services, INC. | $329.00 | 2019-2025 | Vistaseal |
| Conmed Corporation | $163.83 | 2023-2025 | Airseal |
| Dilon Technologies, INC. | $141.48 | 2025 | Hemoblast Bellows |
| Ethicon US, LLC | $110.16 | 2021 | |
| Csl Behring | $27.77 | 2024 | Kcentra |
| Idorsia Pharmaceuticals US INC | $16.40 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.